联影医疗
(688271)
| 流通市值：738.00亿 | | | 总市值：1025.17亿 |
| 流通股本：5.93亿 | | | 总股本：8.24亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,954,283,174.55 | 5,333,486,253.17 | 2,350,478,362.11 | 11,410,765,602.39 |
| 营业收入 | 6,954,283,174.55 | 5,333,486,253.17 | 2,350,478,362.11 | 11,410,765,602.39 |
| 二、营业总成本 | 6,608,289,860.41 | 4,564,826,089.38 | 2,055,132,564.46 | 9,857,946,495.53 |
| 营业成本 | 3,518,012,196.57 | 2,646,865,179.76 | 1,185,383,044.59 | 5,878,580,949.27 |
| 税金及附加 | 36,559,730.57 | 27,173,585.08 | 11,871,069.33 | 69,491,966.37 |
| 销售费用 | 1,385,289,095.62 | 891,366,003.06 | 357,708,220.26 | 1,769,512,581.9 |
| 管理费用 | 411,739,490.53 | 238,744,275.5 | 121,179,166.33 | 560,706,672.14 |
| 研发费用 | 1,317,598,874.67 | 826,022,924.17 | 419,681,857.09 | 1,728,541,428.81 |
| 财务费用 | -60,909,527.55 | -65,345,878.19 | -40,690,793.14 | -148,887,102.96 |
| 其中:利息费用 | 5,150,408.19 | 3,420,713.91 | 703,529.22 | 7,022,227.79 |
| 其中:利息收入 | -91,794,911.66 | -70,968,434.57 | -39,208,006.08 | -174,671,675.38 |
| 加:公允价值变动收益 | 634,719.17 | 7,410,470.99 | 7,802,116.67 | -6,062,747.97 |
| 加:投资收益 | 72,236,681.41 | 45,034,348.3 | 15,500,994.89 | 110,345,129.18 |
| 资产处置收益 | 623,351.82 | 622,909.34 | - | 13,463.47 |
| 资产减值损失(新) | 50,456,126.82 | 39,520,280.84 | 2,079,721.71 | -42,886,067.58 |
| 信用减值损失(新) | -107,927,266.45 | -73,491,375.32 | -25,584,071.83 | -58,982,635.1 |
| 其他收益 | 355,172,710.2 | 252,502,221.6 | 105,262,737.48 | 586,268,985.13 |
| 营业利润平衡项目 | -0.01 | 0 | 0 | 0 |
| 四、营业利润 | 717,189,637.1 | 1,040,259,019.54 | 400,407,296.57 | 2,141,515,233.99 |
| 加:营业外收入 | 3,634,098.03 | 1,551,981.76 | 950,369.97 | 10,533,540.14 |
| 减:营业外支出 | 8,963,565.27 | 2,013,184.16 | 1,617,125.62 | 9,794,100.22 |
| 利润总额平衡项目 | 0.01 | 0 | 0 | 0 |
| 五、利润总额 | 711,860,169.87 | 1,039,797,817.14 | 399,740,540.92 | 2,142,254,673.91 |
| 减:所得税费用 | 53,470,659.97 | 95,232,490.9 | 37,798,169.16 | 164,499,867.47 |
| 六、净利润 | 658,389,509.9 | 944,565,326.24 | 361,942,371.76 | 1,977,754,806.44 |
| 持续经营净利润 | 658,389,509.9 | 944,565,326.24 | 361,942,371.76 | 1,977,754,806.44 |
| 归属于母公司股东的净利润 | 671,163,083.66 | 950,211,921.88 | 363,297,720.56 | 1,974,292,317.49 |
| 少数股东损益 | -12,773,573.76 | -5,646,595.64 | -1,355,348.8 | 3,462,488.95 |
| (一)基本每股收益 | 0.82 | 1.16 | 0.44 | 2.4 |
| (二)稀释每股收益 | 0.82 | 1.16 | 0.44 | 2.4 |
| 八、其他综合收益 | -7,857,195.81 | 2,233,137.29 | 1,045,318.26 | 13,750,597.25 |
| 归属于母公司股东的其他综合收益 | -7,857,195.81 | 2,233,137.29 | 1,045,318.26 | 13,750,597.25 |
| 九、综合收益总额 | 650,532,314.09 | 946,798,463.53 | 362,987,690.02 | 1,991,505,403.69 |
| 归属于母公司股东的综合收益总额 | 663,305,887.85 | 952,445,059.17 | 364,343,038.82 | 1,988,042,914.74 |
| 归属于少数股东的综合收益总额 | -12,773,573.76 | -5,646,595.64 | -1,355,348.8 | 3,462,488.95 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |